EntrarCadastrar

/

Letrozole

CAS 112809-51-5

Visão geral

Letrozole is an aromatase inhibitor sold under the brand name Femra, which is used to treat hormone-responsive breast cancer after surgery. It was patented in 1986 and approved for medical use in 1996

A Anant Labs fabrica e fornece impurezas de Letrozole de alta qualidade para o mercado global. Nossas impurezas EP de Letrozole são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Ingrediente Farmacêutico Ativo

Chemical structure of Letrozole

Letrozole

Cat. No.: ANT-LTZ-000
CAS: 112809-51-5
Mol. Formula: C₁₇H₁₁N₅
Mol. Weight: 285.3

Impurezas (5)

Chemical structure of 1,4-bis[(4-cyanophenyl)methyl]-1H-1,2,4-triazol-4-ium bromide

1,4-bis[(4-cyanophenyl)methyl]-1H-1,2,4-triazol-4-ium bromide

Cat. No.: ANT-LTZ-003
CAS: NA
Mol. Formula: C₁₈H₁₄BrN₅
Mol. Weight: 380.24

Chemical structure of Letrozole Diacid

Letrozole Diacid

Cat. No.: ANT-LTZ-004
CAS: 1644566-39-1
Mol. Formula: C₁₇H₁₅N₃O₄
Mol. Weight: 323.31

Chemical structure of Letrozole Diamide

Letrozole Diamide

Cat. No.: ANT-LTZ-005
CAS: 2170106-13-3
Mol. Formula: C₁₇H₁₇N₅O₂
Mol. Weight: 323.36

Chemical structure of Letrozole Dimer

Letrozole Dimer

Cat. No.: ANT-LTZ-01
CAS: NA
Mol. Formula: C₁₈H₁₄BrN₅
Mol. Weight: 380.25

Chemical structure of Letrozole Impurity B

Letrozole Impurity B

Cat. No.: ANT-LTZ-02
CAS: 113402-31-6
Mol. Formula: C₂₂H₁₃N₃
Mol. Weight: 319.36